Detection of KIT and FLT3 Mutations in Acute Myeloid Leukemia with Different Subtypes

作者: Farhad Zaker , Mohammad Mohammadzadeh , Mohammad Mohammadi , None

DOI:

关键词:

摘要: Background: Mutations in KIT and fms-like tyrosine kinase 3 genes lead to uncontrolled proliferation of leukemic cells with a poor prognosis. Since, data concerning the incidence associations patients characteristics vary amongst different studies, aim present study is identify quantify frequency mutations Iranian suffering from acute myeloid leukemia. Methods: Internal tandem duplication D835 gene leukemia were studied through polymerase chain reaction reaction-RFLP analysis. Amplified products for point mutation D816 have also been identified technique. The exon 8 detected by using PCR Conformational Sensitive Gel Electrophoresis techniques, amplified confirmed sequencing techniques. Results: occurred 18% 6% AML patients, respectively. Frequencies 1.4% 4.7% patients. These results substantially various subclasses French-American-British classification. Conclusion: This revealed that approximately 30% either or genetic mutations. presence was significantly associated M3 morphology M2 M4 subtypes.

参考文章(31)
Alessandro Beghini, Paolo Peterlongo, Carla B. Ripamonti, Lidia Larizza, Roberto Cairoli, Enrica Morra, Cristina Mecucci, C-kit mutations in core binding factor leukemias. Blood. ,vol. 95, pp. 726- 728 ,(2000) , 10.1182/BLOOD.V95.2.726
Masao Mizuki, Regina Fenski, Hartmut Halfter, Itaru Matsumura, Rainer Schmidt, Carsten Müller, Wolfram Grüning, Karsten Kratz-Albers, Susanne Serve, Claudia Steur, Thomas Büchner, Joachim Kienast, Yuzuru Kanakura, Wolfgang E. Berdel, Hubert Serve, Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood. ,vol. 96, pp. 3907- 3914 ,(2000) , 10.1182/BLOOD.V96.12.3907
S Misawa, S Horiike, K Kashima, H Kaneko, T Iwai, M Nakao, S Yokota, T Fujimoto, Y Sonoda, Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia. ,vol. 10, pp. 1911- 1918 ,(1996)
Animesh Pardanani, Ayalew Tefferi, Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders. Blood. ,vol. 104, pp. 1931- 1939 ,(2004) , 10.1182/BLOOD-2004-01-0246
Tomasz Skorski, Oncogenic tyrosine kinases and the dna-damage response Nature Reviews Cancer. ,vol. 2, pp. 351- 360 ,(2002) , 10.1038/NRC799
Derek L. Stirewalt, Jerald P. Radich, The role of FLT3 in haematopoietic malignancies Nature Reviews Cancer. ,vol. 3, pp. 650- 665 ,(2003) , 10.1038/NRC1169
Yasuhiro Moriyama, Tohru Tsujimura, Koji Hashimoto, Masahiro Morimoto, Hitoshi Kitayama, Yuji Matsuzawa, Yukihiko Kitamura, Yuzuru Kanakura, Role of Aspartic Acid 814 in the Function and Expression of c-kit Receptor Tyrosine Kinase Journal of Biological Chemistry. ,vol. 271, pp. 3347- 3350 ,(1996) , 10.1074/JBC.271.7.3347
Susanne Schnittger, Tobias M. Kohl, Torsten Haferlach, Wolfgang Kern, Wolfgang Hiddemann, Karsten Spiekermann, Claudia Schoch, KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival Blood. ,vol. 107, pp. 1791- 1799 ,(2006) , 10.1182/BLOOD-2005-04-1466
D. Gary Gilliland, James D. Griffin, Role of FLT3 in leukemia Current Opinion in Hematology. ,vol. 9, pp. 274- 281 ,(2002) , 10.1097/00062752-200207000-00003